ATE373009T1 - Verfahren zur vorbereitung von telithromycin - Google Patents

Verfahren zur vorbereitung von telithromycin

Info

Publication number
ATE373009T1
ATE373009T1 AT05775551T AT05775551T ATE373009T1 AT E373009 T1 ATE373009 T1 AT E373009T1 AT 05775551 T AT05775551 T AT 05775551T AT 05775551 T AT05775551 T AT 05775551T AT E373009 T1 ATE373009 T1 AT E373009T1
Authority
AT
Austria
Prior art keywords
formula
xiia
benzoyl
deoxy
imidazol
Prior art date
Application number
AT05775551T
Other languages
English (en)
Inventor
Suhas Sohani
Mandar Deodhar
Nishant Patel
Manish Patel
Mahesh Davadra
Vinodkumar Kansal
Original Assignee
Alembic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Ltd filed Critical Alembic Ltd
Application granted granted Critical
Publication of ATE373009T1 publication Critical patent/ATE373009T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT05775551T 2004-04-28 2005-04-25 Verfahren zur vorbereitung von telithromycin ATE373009T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN491MU2004 2004-04-28

Publications (1)

Publication Number Publication Date
ATE373009T1 true ATE373009T1 (de) 2007-09-15

Family

ID=35159987

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05775551T ATE373009T1 (de) 2004-04-28 2005-04-25 Verfahren zur vorbereitung von telithromycin

Country Status (10)

Country Link
US (1) US20070260066A1 (de)
EP (1) EP1742957B1 (de)
AT (1) ATE373009T1 (de)
AU (1) AU2005238313A1 (de)
CA (1) CA2559281A1 (de)
DE (1) DE602005002475T2 (de)
ES (1) ES2294733T3 (de)
PL (1) PL1742957T3 (de)
SI (1) SI1742957T1 (de)
WO (1) WO2005105821A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1638549A4 (de) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc Neue antibakterielle mittel
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
WO2007049296A2 (en) * 2005-10-28 2007-05-03 Alembic Limited Amorphous form of telithromycin
US20070167382A1 (en) * 2005-11-15 2007-07-19 Nina Finkelstein Crystalline and amorphous forms of telithromycin
WO2007069264A2 (en) * 2005-12-15 2007-06-21 Alembic Limited Reference standards for determining the purity of telithromycin and processes therefor
GB0600238D0 (en) 2006-01-06 2006-02-15 Sandoz Ag Organic compounds
WO2008007388A1 (en) * 2006-07-12 2008-01-17 Alembic Limited Novel process for the preparation of telithromycin
WO2008023383A1 (en) * 2006-08-25 2008-02-28 Alembic Limited Novel process for the preparation of telithromycin
ES2306590B1 (es) * 2006-12-15 2009-08-07 Ercros Industrial,S .A. Formas cristalinas i y ii de telitromicina.
ES2310121B1 (es) * 2007-04-19 2009-09-11 Ercros Industrial, S.A. Nuevo proceso de sintesis de telitromicina.
US20110040078A1 (en) * 2007-10-25 2011-02-17 Siegfried Wolf Process for the production of telithromycin
EP2214484A4 (de) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc Verfahren zur herstellung von antibakteriellen makrolid-wirkstoffen
JP5711135B2 (ja) 2008-10-24 2015-04-30 センプラ ファーマシューティカルズ,インコーポレイテッド 胃腸疾患を治療するための方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
MX361413B (es) 2010-03-22 2018-12-05 Cempra Pharmaceuticals Inc Star Formas cristalinas de un macrólido y usos para las mismas.
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (de) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc Wasserstoffbindung zur formung von fluorketoliden zur behandlung von krankheiten
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2732684B1 (fr) * 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
EP1742957A2 (de) 2007-01-17
SI1742957T1 (sl) 2008-04-30
WO2005105821A2 (en) 2005-11-10
DE602005002475T2 (de) 2008-05-29
ES2294733T3 (es) 2008-04-01
PL1742957T3 (pl) 2008-05-30
AU2005238313A1 (en) 2005-11-10
DE602005002475D1 (de) 2007-10-25
EP1742957B1 (de) 2007-09-12
WO2005105821A3 (en) 2006-04-27
CA2559281A1 (en) 2005-11-10
US20070260066A1 (en) 2007-11-08

Similar Documents

Publication Publication Date Title
ATE373009T1 (de) Verfahren zur vorbereitung von telithromycin
JO2893B1 (en) Chemical method
NO20082338L (no) Pyrimidinderivater for behandling av avvikende cellevekst
NO20063501L (no) Kinolinintermediater av reseptor-Tyrosin-Kinase-inhibitorer og deres syntese
DE60316688D1 (de) Dehydrophenylahistine und analoge davon sowie ein verfahren zur herstellung von dehydrophenylahistinen und analogen davon
GEP20115171B (en) Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
NO20064077L (no) Kemokinreseptorantagonister
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
PT2049480E (pt) Derivados de 2-arilindole como inibidores da mpges-i
ITMI20022076A1 (it) Sali di intermedi del cefdinir.
NO20070089L (no) DPP-IV inhibitorer
WO2007032028A8 (en) Thiazolinones and oxazolinones and their use as ptp1b inhibitors
DK1513800T3 (da) Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse
ATE553095T1 (de) Neue imidazolderivate, deren herstellung und deren verwendung als intermediate zur herstellung von arzneimitteln und pestiziden
ATE521606T1 (de) Quaternäre ammoniumsalze als m3-antagonisten
ATE420875T1 (de) Verfahren zur herstellung von 5-(4-ä4-(5-cyano-3- indolyl)-butylü-1-piperazinyl)-benzofuran-2- carboxamid
NO20064351L (no) Caspaseinhibitorer og anvendelser derav
EA201001252A1 (ru) Способ получения производных 3,6-дигидро-1,3,5-триазина
TW200505869A (en) Thiophenylaminoimidazolines
WO2006066044A3 (en) Processes for producing 4-aminoquinazolines
FR2840900B1 (fr) Nouveaux derives d'aryl[4-halogeno-4- [(heteroaryl-methylamino)-methyl]-piperidin-1-yl]-methanone, leur procede de preparation et leur utilisation a titre de medicaments
ATE526312T1 (de) Verfahren zur herstellung von reinen 4- pyrrolidinophenylbenzyletherderivaten als maob- inhibitoren
MY145540A (en) Chemical process
ATE280769T1 (de) Verfahren zur herstellung von vitronectin- rezeptorantagonisten
TW200600013A (en) 5,6-Dialkyl-7-aminotriazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties